Eupraxia Pharmaceuticals Inc (EPRX) Stock Price & News

EPRX:TSE

Eupraxia Pharmaceuticals Inc

CA$10.86

+3.82%

(+0.40) 1D

Nov 10, 4:00:00 PM GMT-5 · CAD

All symbols

	Symbol	Price	Change	% Change

Last report

Nov 10, 2026

Fiscal period

Q3 2026

-CA$0.33 / -

Revenue / Est. (CAD)

- / 0.00

Fiscal Q3 2026 earnings call

Waiting for the earnings call

At a glance

Insights from the latest news and reports

Previous reportsAll values in CAD

Loading Previous Earnings...

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	4.42M	7.87M	11.17M	12.81M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2.47M	8.30M	4.78M	5.30M
Operating expense	6.88M	16.16M	15.96M	18.10M
Total operating expenses	6.88M	16.16M	15.96M	18.10M
Operating income	-6.88M	-16.16M	-15.96M	-18.10M
Other non operating income	-	-	-	-
EBT including unusual items	-6.37M	-16.71M	-12.64M	-14.46M
EBT excluding unusual items	-6.37M	-16.71M	-12.64M	-14.46M
Income tax expense	-623.00	11.34K	13.90K	30.38K
Effective tax rate	0.01%	-0.07%	-0.11%	-0.21%
Other operating expenses	-	-	-	-
Net income	-6.36M	-16.71M	-12.65M	-14.49M
Net profit margin	-	-	-	-
Earnings per share	-0.19	-	-	-
Interest and investment income	180.18K	666.92K	1.07M	1.39M
Interest expense	-	-	-	-
Net interest expenses	180.18K	666.92K	1.07M	1.39M
Depreciation and amortization charges	-	-	-	-
EBITDA	-6.84M	-16.11M	-15.90M	-18.02M
Gain or loss from assets sale	-	1.49K	-	2.70K

Finance